Lineweaver Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Buy
8,159
+407
+5% +$139K 0.35% 63
2026
Q1
$2.73M Buy
7,752
+108
+1% +$38.5K 0.37% 58
2025
Q4
$2.5M Buy
7,644
+491
+7% +$156K 0.34% 58
2025
Q3
$2.02M Buy
7,153
+822
+13% +$238K 0.3% 65
2025
Q2
$1.77M Buy
6,331
+688
+12% +$195K 0.28% 74
2025
Q1
$1.76M Buy
5,643
+731
+15% +$216K 0.3% 67
2024
Q4
$1.28M Buy
4,912
+3,723
+313% +$1.1M 0.24% 80
2024
Q3
$383K Buy
1,189
+17
+1% +$5.56K 0.07% 106
2024
Q2
$367K Sell
1,172
-396
-25% -$116K 0.08% 107
2024
Q1
$445K Buy
1,568
+9
+0.6% +$2.63K 0.11% 104
2023
Q4
$449K Sell
1,559
-46
-3% -$12.5K 0.12% 103
2023
Q3
$431K Buy
1,605
+185
+13% +$46.2K 0.13% 100
2023
Q2
$316K Sell
1,420
-45
-3% -$10.4K 0.09% 100
2023
Q1
$354K Buy
1,465
+38
+3% +$9.33K 0.11% 100
2022
Q4
$374K Sell
1,427
-31
-2% -$8.31K 0.11% 95
2022
Q3
$328K Sell
1,458
-3
-0.2% -$727 0.11% 101
2022
Q2
$355K Buy
1,461
+35
+2% +$8.58K 0.12% 97
2022
Q1
$345K Sell
1,426
-47
-3% -$10.8K 0.1% 108
2021
Q4
$331K Sell
1,473
-149
-9% -$31.4K 0.1% 106
2021
Q3
$344K Buy
1,622
+37
+2% +$8.52K 0.11% 99
2021
Q2
$386K Buy
1,585
+69
+5% +$17K 0.13% 81
2021
Q1
$377K Buy
1,516
+141
+10% +$33.6K 0.13% 76
2020
Q4
$316K Buy
1,375
+42
+3% +$9.68K 0.12% 74
2020
Q3
$338K Buy
1,333
+258
+24% +$63.9K 0.15% 64
2020
Q2
$253K Buy
+1,075
New +$245K 0.13% 71

Other funds holding AMGN

Lineweaver Wealth Advisors's AMGN Position: Q2 2026 in Review

Lineweaver Wealth Advisors increased its Amgen (AMGN) stake by 5.3% in Q2 2026, buying an estimated $139K and bringing the position to 8,159 shares worth $2.95M. The position accounts for 0.35% of the portfolio, ranked #63.

Lineweaver Wealth Advisors first reported a position in AMGN in Q2 2020 and has held it in 25 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lineweaver Wealth Advisors held 8,159 shares of Amgen worth $2.95M as of Q2 2026.
  • Lineweaver Wealth Advisors bought 407 Amgen shares in Q2 2026, an estimated $139K.
  • Amgen made up 0.35% of Lineweaver Wealth Advisors's portfolio in Q2 2026, its #63 holding.
  • Lineweaver Wealth Advisors first reported a position in Amgen in Q2 2020 and has held it in 25 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lineweaver Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.